Acuta Capital Partners LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Acuta Capital Partners LLC
CRD #158869
SEC #801-136966
CIK #0001582844, 0000158284
AUM 172.5 M (2026-06-30)
Employees 4 (75% Investors, 0% Brokers)
Phone650-486-0508
Address255 Shoreline Drive
Redwood City, CA 94065
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
80064048032016002010201520212027
Sector Form 13F Holdings Value ($M)
Praxis Precision Medicines Inc 27.4
Zeta Acquisition Corp II 11.8
BCTG Acquisition Corp 9.2
Bright Minds Biosciences Inc 8.2
Erasca Inc 5.7
Consonance-HFW Acquisition Corp 5.0
Ocular Therapeutix Inc 5.0
Olivia Ventures Inc 4.5
Minerva Neurosciences Inc 4.3
Helix Acquisition Corp 3.6
View All
Holdings by Sector ($M)
70056042028014002015201920232027
Type Form D Funds Date Sold AUM
HF Acuta Capital Fund LP [2015-04-01] 265.1 M 130.3 M
Filed 2020-03-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Acuta Opportunity Fund LP [2015-04-01] 72.4 M 42.3 M
Filed 2020-03-16 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
VC Acuta Ventures LP [2015-04-01] 9.0 M 64.4 M
Filed 2019-03-18 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 172.5
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 172.5
By Discretionary
Discretionary 3 172.5
Non-Discretionary 0 0.0
Total 3 172.5
By Non-United States Persons
Non-United States Persons 2.1
United States Persons 170.4
Total 3 172.5
Form D Directors Role # Filings # Firms 2011 - 2026
Richard Lin Executive Officer, Promoter 25 3
Anupam Dalal Executive Officer 18 3
Manfred Yu Executive Officer 5 2
Longwood Capital Partners LLC Promoter 5 2
Acuta Capital Partners LLC Promoter 5 2
Longwood Capital Partners Promoter 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001582844]
SC 13D [0001582844]
SC 13G [0001582844]
Form 13D/13G Filer Form 13D/13G Subject Filed
Acuta Capital Partners LLC BCLS Acquisition Corp [2022-02-15]
Acuta Capital Partners LLC AADI Bioscience Inc [2021-09-07]
Acuta Capital Partners LLC Vistagen Therapeutics Inc [2021-03-22]
Acuta Capital Partners LLC Catalyst Biosciences Inc [2021-02-16]
Acuta Capital Partners LLC JIYA Acquisition Corp [2021-02-16]
Acuta Capital Partners LLC Larimar Therapeutics Inc [2021-02-16]
Acuta Capital Partners LLC Vistagen Therapeutics Inc [2021-02-16]
Acuta Capital Partners LLC Kadmon Holdings Inc [2020-02-14]
Acuta Capital Partners LLC Iridex Corp [2019-11-13]
Acuta Capital Partners LLC Assembly Biosciences Inc [2019-02-14]
Acuta Capital Partners LLC CAS Medical Systems Inc [2019-02-14]
Acuta Capital Partners LLC Catalyst Biosciences Inc [2019-02-14]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14]
Acuta Capital Partners LLC Iridex Corp [2019-02-14]
Acuta Capital Partners LLC Kadmon Holdings Inc [2019-02-14]
Acuta Capital Partners LLC Veracyte Inc [2019-02-14]
Acuta Capital Partners LLC Intec Pharma Ltd [2018-10-09]
Acuta Capital Partners LLC Intec Pharma Ltd [2018-02-14]
Acuta Capital Partners LLC Kadmon Holdings Inc [2018-02-14]
Acuta Capital Partners LLC Veracyte Inc [2018-02-14]
Acuta Capital Partners LLC CAS Medical Systems Inc [2018-02-14]
Acuta Capital Partners LLC Chembio Diagnostics Inc [2018-02-14]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14]
Acuta Capital Partners LLC Catalyst Biosciences Inc [2018-02-14]
Acuta Capital Partners LLC Iridex Corp [2018-02-14]
Acuta Capital Partners LLC Assembly Biosciences Inc [2018-02-14]
Acuta Capital Partners LLC Intec Pharma Ltd [2017-09-08]
Acuta Capital Partners LLC Chembio Diagnostics Inc [2017-06-12]
Acuta Capital Partners LLC CAS Medical Systems Inc [2017-02-13]
Acuta Capital Partners LLC Chembio Diagnostics Inc [2017-02-13]
Acuta Capital Partners LLC Iridex Corp [2017-02-13]
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13]
Acuta Capital Partners LLC Veracyte Inc [2017-02-13]
Acuta Capital Partners LLC Assembly Biosciences Inc [2017-02-13]
Acuta Capital Partners LLC Iridex Corp [2016-07-08]
Acuta Capital Partners LLC Combimatrix Corp [2016-02-12]
Acuta Capital Partners LLC Veracyte Inc [2016-02-12]
Acuta Capital Partners LLC CAS Medical Systems Inc [2016-02-12]
Longwood Capital Partners LLC Combimatrix Corp [2015-02-09]
Longwood Capital Partners LLC Combimatrix Corp [2014-01-03]
Longwood Capital Partners LLC Idera Pharmaceuticals Inc [2013-07-30]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI254900E1CS9VUALU2O96
Comparable Firms State AUM
Nine Left Capital LP
NY 176.1 M
Three Bridges Capital LP
NY 175.5 M
Teca Partners LP
TX 174.8 M
Barington Companies Investors LLC
NY 172.9 M
Counter Global LP
CA 172.7 M
Nightview Capital LLC
FL 171.9 M
Stillpoint Investments LP
NY 169.8 M
Stone House Capital Management LLC
FL 169.8 M
Baleen Capital Management LLC
NV 168.7 M
Staines Financial LLC
CA 168.7 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com